<DOC>
	<DOC>NCT00705978</DOC>
	<brief_summary>This study will provide efficacy data for Creon 40,000 in CP subjects as well as long-term safety data. During the long-term treatment with Creon 40,000 nutritional parameters will be assessed and correlated with CFA.</brief_summary>
	<brief_title>Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis</brief_title>
	<detailed_description />
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pancreatitis, Chronic</mesh_term>
	<mesh_term>Exocrine Pancreatic Insufficiency</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<criteria>Inclusion Criteria Pancreatic exocrine insufficiency has to be proven (in medical history) by a pancreatic function test Chronic pancreatitis has to be proven (in medical history) by CT, ERCP, plain film with pancreatic calcifications, ultrasonography (calcifications,duct dilatation) and /or histology Females must be nonlactating and either be of nonchildbearing potential or if of childbearing potential, agree to practice effective barrier contraceptive methods, use an intrauterine device (IUD) or use birth control pills or equivalent injectable contraceptive. The subject must have been practicing the selected method of birth control for at least 3 months prior to Visit 1 (Day 14). Subjects with a pathological stool fat during run in period (&gt; 10g/24 h) Exclusion Criteria Ileus or acute abdomen Any type of malignancy involving the digestive tract in the last 5 years Presence of pseudo pancreatic cysts &gt;= 4 cm Current excessive intake of alcohol or drug abuse Hypersensitivity vs porcine proteins / pancreatin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis</keyword>
</DOC>